CUPR

Cuprina Holdings (Cayman) Limited
CAPPED RATING

Cuprina Holdings (Cayman) Limited (CUPR) is rated C (2.2/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Growth (A+); its weakest is Profitability (F). The rating has held at C for 2 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.2 / 5.0
C
Value
D
Factor Score 1.3 / 5.0
Growth
A+
Factor Score 5.0 / 5.0
Profitability
F
Factor Score 0.3 / 5.0
Momentum
C-
Factor Score 2.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA -1.0
Rev Growth YoY 267.4%
Gross Margin -1.3%
Price Return 3M -41.3%
Price Return 12M -73.6%
Catalyst Signal 0.00
Market Cap $13.5M
TTM Revenue $49.9K
Price / Sales 269.9
ROE N/M

Historical Factor Score Progression

Held C for 2 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 D (1.3) A+ (5.0) F (0.3) C- (2.0) C+ (2.6) C (2.2)
2026-11-04 D (1.2) A+ (5.0) F (0.3) D+ (1.8) C+ (2.7) C (2.2)
2026-10-28 D (1.5) A+ (5.0) F (0.3) D (1.5) C+ (2.7) C (2.2)
2026-10-21 D (1.5) A+ (5.0) F (0.3) D (1.3) C+ (2.6) C- (2.1)
2026-10-14 D (1.5) A+ (5.0) F (0.3) D+ (1.6) C+ (2.6) C (2.2)
Page 1 of 4